On September 15, 2023, the Board of Directors of Ocugen, Inc. (the “Company”) appointed Michael Breininger, who is currently the Corporate Controller, as the Company’s Interim Chief Accounting Officer and principal financial officer, effective as of September 15, 2023.
In addition, effective as of September 15, 2023, (i) Shankar Musunuri, Ph.D., MBA, the Company’s Chairman, Chief Executive Officer & Co-Founder , is no longer serving as the Company’s interim principal financial officer
Jamere Jackson, currently Chief Financial Officer and Executive Vice President, Finance and Store Development, has been promoted to the position of Chief Financial Officer (CFO) where he will continue to lead the Finance and Store Development teams;
On September 19, 2023, the Company announced the appointment of Bryan Castellani as Executive Vice President, Chief Financial Officer (“CFO”), effective October 16, 2023.
On March 14, 2023, Warner Music Group Corp. (the “Company”) announced that it had begun planning for the succession of the Company’s Chief Financial Officer, Eric Levin.
Upon and subject to the completion of the Merger, Mr. Sheahan, Chairman, President and Chief Executive Officer of Cambridge, will become the Chief Executive Officer of the Company and will join the Company’s Board of Directors.
Departed
(interim)
Tyler Danielson
Interim Chief Executive Officer and Chief Technology Officer
On September 13, 2023, Tyler Danielson notified the Company of his decision to resign as Interim Chief Executive Officer and Chief Technology Officer of the Company, effective as of September 14, 2023.
appointed Mark White to serve as Interim Chief Executive Officer of the Company, effective as of Mr. White’s entry into his employment agreement with the Company
Martin Ward to serve as Interim Chief Financial Officer of the Company, effective as of Mr. Ward’s entry into his employment agreement with the Company
On and effective as of September 15, 2023, Anthony Fidaleo departed as our Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer and Treasurer (collectively, our “ CFO ”).
Mark Thomas, our current Chief Executive Officer, Principal Executive Officer and President since January 10, 2023, has agreed to serve as our acting CFO on an interim basis until such time as we appoint a new permanent CFO.
Role change
Albert N. Marchio, II
Chief Executive Officer, Chief Financial Officer, and Secretary
Fresh Tracks Therapeutics, Inc.
Effective
2023-10-02
Filed
September 19, 2023, 7:59 PM ET
the Board appointed Albert N. Marchio, II, the Company’s current Chief Financial Officer, as the Company’s new Chief Executive Officer, Chief Financial Officer, and Secretary, as well as a director and Chairman of the Board, in each case effective October 2, 2023.
Departed
Andrew D. Sklawer
President and Chief Executive Officer
Fresh Tracks Therapeutics, Inc.
Effective
2023-10-02
Successor
Albert N. Marchio, II
Filed
September 19, 2023, 7:59 PM ET
the Board of Directors (the “Board”) of the Company terminated Andrew D. Sklawer, the Company’s President and Chief Executive Officer, without cause, effective October 2, 2023.
On September 15, 2023, Mr. Earl Johnson submitted to the Board of Directors (“Board”) of Tego Cyber Inc. (the “Company”) his resignation as Chief Financial Officer, effective immediately.
Paul K. Ito was appointed Senior Vice President, CFO and Treasurer of Hawaiian Electric and will resign as Executive Vice President, CFO and Treasurer of Hawaiian Electric Industries, Inc. (HEI) effective as of October 1, 2023.
Appointed
(interim)
Scott DeGhetto
Executive Vice President, Chief Financial Officer and Treasurer
In connection with the retirement of Tayne Sekimura as Senior Vice President, Chief Financial Officer (CFO) and Treasurer of Hawaiian Electric Company, Inc. (Hawaiian Electric) on September 30, 2023,
Departed
Paul K. Ito
Executive Vice President, Chief Financial Officer and Treasurer
Tom Vadaketh informed Bausch Health Companies Inc. (the “Company”) of his decision to resign as the Executive Vice President, Chief Financial Officer of the Company.
John S. Barresi, who is currently serving as the Company’s Senior Vice President, Controller and Chief Accounting Officer, will assume the additional role of interim Chief Financial Officer.
On September 13, 2023, the Company also announced that John Canning will be leaving the Company as Chief Financial Officer effective as of the expiration of his employment agreement on September 13, 2023.
On September 14, 2023, Bernard McCracken, the Interim Chief Financial Officer, and Vice President, Controller and Chief Accounting Officer of Lands’ End, Inc. (the “Company”) was appointed Chief Financial Officer of the Company.
On September 18, 2023, Black Diamond Therapeutics, Inc. (the “Company”) announced that it separated with David M. Epstein, Ph.D. as President and Chief Executive Officer and principal executive officer of the Company, in each case, effective as of September 15, 2023
Effective September 16, 2023, the Board appointed Mark A. Velleca, M.D., Ph.D. as President and Chief Executive Officer and principal executive officer of the Company
Thereafter, Mr. Smith will continue to serve as WUP’s Chief Financial Officer and the Company’s principal financial officer and principal accounting officer.
the Company announced that the Board of Directors of the Company appointed George N. Mattson to serve as Chief Executive Officer of Wheels Up Partners LLC
Appointed
(interim)
Sandra A. Gardiner
interim Chief Financial Officer
Kronos Bio, Inc.
Effective
2023-09-15
Filed
September 18, 2023, 7:59 PM ET
On September 14, 2023, the Board of Directors of Kronos Bio, Inc. (the “Company”) appointed Sandra A. Gardiner as the Company’s interim Chief Financial Officer, as well as the Company’s principal financial officer and principal accounting officer, effective at the close of business on September 15, 2023.
Role change
Gerry P. Smith
Chief Executive Officer
ODP Corp
Effective
2023-09-18
Filed
September 18, 2023, 7:59 PM ET
Gerry P. Smith, the Chief Executive Officer of the Company (“CEO”), began a temporary medical leave of absence to undergo a medical procedure that requires several weeks of recovery.
Appointed
(interim)
Joseph S. Vassalluzzo
Chief Executive Officer (interim)
ODP Corp
Effective
2023-09-18
Filed
September 18, 2023, 7:59 PM ET
the Board of Directors of the Company (the “Board”) has appointed Joseph S. Vassalluzzo, the Company’s non-executive Chair of the Board, to assume Mr. Smith’s authority and responsibilities until Mr. Smith returns from his medical leave.
appointment of Bradley T. Camden, Senior Vice President and Treasurer, as Interim Chief Financial Officer and the Company’s principal financial officer, effective September 13, 2023.
Appointed
(interim)
Sebastian Holl
Interim Chief Executive Officer and member of the Board
Jeffrey Lubchansky was removed immediately as Chief Executive Officer of the Company and sole member of the Company Board of Directors (the “Board”).
Appointed
Lauren White
Senior Vice President and Chief Financial Officer
ImmunoGen, Inc.
Effective
2023-09-18
Filed
September 18, 2023, 7:59 PM ET
Effective September 18, 2023, ImmunoGen, Inc. (the “Company”) appointed Lauren White as Senior Vice President and Chief Financial Officer and designated her as the Company’s principal financial officer.
Effective immediately following Ms. Kinder’s departure, Todd Wilson, the Company’s Chief Financial Officer, will assume the responsibilities of principal accounting officer.
Appointed
(interim)
Mathieu Riffel
Acting Chief Financial Officer
Terran Orbital Corp
Effective
2023-09-15
Filed
September 15, 2023, 7:59 PM ET
Also on September 15, 2023, the Company appointed Mathieu Riffel (age 38) as Acting Chief Financial Officer, effective immediately.
the Company entered into a Retention Agreement with Brad Bollner, the Company's Vice President of Finance and, effective October 1, 2023, the Company's interim Chief Financial Officer
approved the grant to John Moore, the Company's Head of Coffee and, effective October 1, 2023, the interim Chief Executive Officer
Departed
David P. Jenkins
Chief Financial Officer
Gardiner Healthcare Acquisitions Corp.
Effective
2023-09-19
Filed
September 15, 2023, 7:59 PM ET
On September 11, 2023, David P. Jenkins notified Gardiner Healthcare Acquisitions Corp., a Delaware corporation (the “Company”), of his decision to resign as Chief Financial Officer (“CFO”), effective September 19, 2023, to pursue other opportunities.
On September 13, 2023, Coherent Corp. (the “Company”) and Mary Jane Raymond, the Company’s Chief Financial Officer, Treasurer and principal financial officer (“CFO”), mutually agreed that she would conclude her services as the Company’s CFO as of September 29, 2023 (the “Effective Date”).
On September 13, 2023, the Board of Directors of the Company (the “Board”) appointed Richard Martucci (age 55), the Company’s Senior Vice President, Business Operations, to serve as its interim Chief Financial Officer and Treasurer and principal financial officer (“Interim CFO”), effective as of September 30, 2023 and until a permanent successor is identified.
Departed
Frank A. Riddick III
principal financial officer
WORLD WRESTLING ENTERTAINMENT, LLC
Effective
2023-09-12
Filed
September 15, 2023, 7:59 PM ET
the principal financial officer of World Wrestling Entertainment, Inc. (n/k/a World Wresting Entertainment, LLC) (the “Company”), Frank A. Riddick III, ceased to be an officer of the Company
Appointed
Kim Tobler
Chief Financial Officer, Treasurer and Vice President
On September 15, 2023, Five Point Holdings, LLC (the “Company”) announced the appointment of Kim Tobler as Chief Financial Officer, Treasurer and Vice President of the Company, effective immediately.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.